| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Intellia Therapeutics, Inc.'s insiders have reduced their positions by a net 8,111 shares worth roughly $91K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), NTLA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.18M | - | |
| Dir | 207.5K | $2.49M | - | |
| CFO | 148.2K | $1.78M | -8,111 | |
| Dir | 134.7K | $1.62M | - | |
| VP | 121.2K | $1.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 4,608 | $29.50 | $135,954.30 | -5.1% | -14.9% | -58.6% | |
| Oct 31, 2023 | Bhanji Muna57 | Director | Sell | 265 | $23.90 | $6,333.50 | -2.2% | +4.5% | -42.8% | |
| Jul 31, 2023 | Bhanji Muna57 | Director | Sell | 265 | $42.33 | $11,217.45 | -2.1% | -43.7% | -37.9% | |
| Jul 6, 2023 | Bhanji Muna57 | Director | Sell | 1,867 | $39.30 | $73,373.10 | -13.0% | -26.0% | -41.8% | |
| Jul 3, 2023 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 360 | $40.51 | $14,583.60 | -0.8% | -27.8% | -45.6% | |
| Jun 20, 2023 | Clark Eliana75 | EVP, Chief Technical Officer | Sale+OE | 5,000 | $45.00 | $225,000.00 | -10.0% | -19.7% | -44.6% | |
| Mar 2, 2023 | Basta James72 | EVP, General Counsel | Sell | 1,088 | $43.88 | $47,741.44 | -1.9% | -15.3% | -25.8% | |
| Jan 5, 2023 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sell | 4,838 | $37.82 | $182,981.60 | -8.0% | -7.7% | -26.2% | |
| Jan 4, 2023 | Leonard John M83 | President And CEO | Sell | 6,673 | $37.21 | $248,302.33 | -0.9% | -7.5% | -24.6% | |
| Jan 4, 2023 | Hicks Derek71 | EVP, Chief Business Officer | Sell | 1,812 | $37.21 | $67,424.52 | -9.5% | -7.5% | -24.6% |